Characterization of the genomic landscape of canine diffuse large B-cell lymphoma reveals recurrent H3K27M mutations linked to progression-free survival

Abstract Diffuse large B-cell lymphoma (DLBCL) is an aggressive hematopoietic neoplasm that affects humans as well as dogs. While previous studies on canine DLBCL (cDLBCL) have significantly advanced our understanding of the disease, the majority of this research has relied on whole-exome sequencing...

Full description

Saved in:
Bibliographic Details
Main Authors: Anna Darlene van der Heiden, Raphaela Pensch, Sophie Agger, Heather L. Gardner, William Hendricks, Victoria Zismann, Shukmei Wong, Natalia Briones, Bryce Turner, Karin Forsberg-Nilsson, Cheryl London, Kerstin Lindblad-Toh, Maja Louise Arendt
Format: Article
Language:English
Published: Nature Portfolio 2025-02-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-89245-0
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823862503182958592
author Anna Darlene van der Heiden
Raphaela Pensch
Sophie Agger
Heather L. Gardner
William Hendricks
Victoria Zismann
Shukmei Wong
Natalia Briones
Bryce Turner
Karin Forsberg-Nilsson
Cheryl London
Kerstin Lindblad-Toh
Maja Louise Arendt
author_facet Anna Darlene van der Heiden
Raphaela Pensch
Sophie Agger
Heather L. Gardner
William Hendricks
Victoria Zismann
Shukmei Wong
Natalia Briones
Bryce Turner
Karin Forsberg-Nilsson
Cheryl London
Kerstin Lindblad-Toh
Maja Louise Arendt
author_sort Anna Darlene van der Heiden
collection DOAJ
description Abstract Diffuse large B-cell lymphoma (DLBCL) is an aggressive hematopoietic neoplasm that affects humans as well as dogs. While previous studies on canine DLBCL (cDLBCL) have significantly advanced our understanding of the disease, the majority of this research has relied on whole-exome sequencing, which is limited in its ability to detect copy number aberrations and other genomic changes beyond coding regions. Furthermore, many of these studies lack sufficient clinical follow-up data, making it difficult to draw meaningful associations between genetic variants and patient outcomes. Our study aimed to characterize the mutational landscape of cDLBCL using whole-genome sequencing of matched tumor-normal samples obtained from a cohort of 43 dogs previously enrolled in a clinical trial for which longitudinal follow-up was available. We focused on identifying genes that were significantly or recurrently mutated with coding point mutations, copy number aberrations, and their associations with patient outcomes. We identified 26 recurrently mutated genes, 18 copy number gains, and 8 copy number losses. Consistent with prior studies, the most commonly mutated genes included TRAF3, FBXW7, POT1, TP53, SETD2, DDX3X and TBL1XR1. The most prominent copy number gain occurred on chromosome 13, overlapping key oncogenes such as MYC and KIT, while the most frequent deletion was a focal loss on chromosome 26, encompassing IGL, PRAME, GNAZ, RAB36, RSPH14, and ZNF280B. Notably, our set of recurrently mutated genes was significantly enriched with genes involved in epigenetic regulation. In particular, we identified hotspot mutations in two histone genes, H3C8, and LOC119877878, resulting in H3K27M alterations predicted to dysregulate gene expression. Finally, a survival analysis revealed that H3K27M mutations in H3C8 were associated with increased hazard ratios for progression-free survival. No copy number aberrations were associated with survival. These findings underscore the critical role of epigenetic dysregulation in cDLBCL and affirm the dog as a relevant large animal model for interrogating the biological activity of novel histone-modifying treatment strategies.
format Article
id doaj-art-a22fe5fbf8e64140bb290d12e32e11ed
institution Kabale University
issn 2045-2322
language English
publishDate 2025-02-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-a22fe5fbf8e64140bb290d12e32e11ed2025-02-09T12:30:21ZengNature PortfolioScientific Reports2045-23222025-02-0115111410.1038/s41598-025-89245-0Characterization of the genomic landscape of canine diffuse large B-cell lymphoma reveals recurrent H3K27M mutations linked to progression-free survivalAnna Darlene van der Heiden0Raphaela Pensch1Sophie Agger2Heather L. Gardner3William Hendricks4Victoria Zismann5Shukmei Wong6Natalia Briones7Bryce Turner8Karin Forsberg-Nilsson9Cheryl London10Kerstin Lindblad-Toh11Maja Louise Arendt12Department of Medical Biochemistry and Microbiology, Uppsala UniversityDepartment of Medical Biochemistry and Microbiology, Uppsala UniversityDepartment of Veterinary Clinical Sciences, University of CopenhagenCummings School of Veterinary Medicine, Tufts UniversityDivision of Integrated Cancer Genomics, Translational Genomics Research Institute (TGen)Division of Integrated Cancer Genomics, Translational Genomics Research Institute (TGen)Division of Integrated Cancer Genomics, Translational Genomics Research Institute (TGen)Division of Integrated Cancer Genomics, Translational Genomics Research Institute (TGen)Division of Integrated Cancer Genomics, Translational Genomics Research Institute (TGen)SciLifeLab, Uppsala UniversityCummings School of Veterinary Medicine, Tufts UniversityDepartment of Medical Biochemistry and Microbiology, Uppsala UniversityDepartment of Medical Biochemistry and Microbiology, Uppsala UniversityAbstract Diffuse large B-cell lymphoma (DLBCL) is an aggressive hematopoietic neoplasm that affects humans as well as dogs. While previous studies on canine DLBCL (cDLBCL) have significantly advanced our understanding of the disease, the majority of this research has relied on whole-exome sequencing, which is limited in its ability to detect copy number aberrations and other genomic changes beyond coding regions. Furthermore, many of these studies lack sufficient clinical follow-up data, making it difficult to draw meaningful associations between genetic variants and patient outcomes. Our study aimed to characterize the mutational landscape of cDLBCL using whole-genome sequencing of matched tumor-normal samples obtained from a cohort of 43 dogs previously enrolled in a clinical trial for which longitudinal follow-up was available. We focused on identifying genes that were significantly or recurrently mutated with coding point mutations, copy number aberrations, and their associations with patient outcomes. We identified 26 recurrently mutated genes, 18 copy number gains, and 8 copy number losses. Consistent with prior studies, the most commonly mutated genes included TRAF3, FBXW7, POT1, TP53, SETD2, DDX3X and TBL1XR1. The most prominent copy number gain occurred on chromosome 13, overlapping key oncogenes such as MYC and KIT, while the most frequent deletion was a focal loss on chromosome 26, encompassing IGL, PRAME, GNAZ, RAB36, RSPH14, and ZNF280B. Notably, our set of recurrently mutated genes was significantly enriched with genes involved in epigenetic regulation. In particular, we identified hotspot mutations in two histone genes, H3C8, and LOC119877878, resulting in H3K27M alterations predicted to dysregulate gene expression. Finally, a survival analysis revealed that H3K27M mutations in H3C8 were associated with increased hazard ratios for progression-free survival. No copy number aberrations were associated with survival. These findings underscore the critical role of epigenetic dysregulation in cDLBCL and affirm the dog as a relevant large animal model for interrogating the biological activity of novel histone-modifying treatment strategies.https://doi.org/10.1038/s41598-025-89245-0DogCanineDiffuse large B-cell lymphomaPrognosisGenomicsOncogenetics
spellingShingle Anna Darlene van der Heiden
Raphaela Pensch
Sophie Agger
Heather L. Gardner
William Hendricks
Victoria Zismann
Shukmei Wong
Natalia Briones
Bryce Turner
Karin Forsberg-Nilsson
Cheryl London
Kerstin Lindblad-Toh
Maja Louise Arendt
Characterization of the genomic landscape of canine diffuse large B-cell lymphoma reveals recurrent H3K27M mutations linked to progression-free survival
Scientific Reports
Dog
Canine
Diffuse large B-cell lymphoma
Prognosis
Genomics
Oncogenetics
title Characterization of the genomic landscape of canine diffuse large B-cell lymphoma reveals recurrent H3K27M mutations linked to progression-free survival
title_full Characterization of the genomic landscape of canine diffuse large B-cell lymphoma reveals recurrent H3K27M mutations linked to progression-free survival
title_fullStr Characterization of the genomic landscape of canine diffuse large B-cell lymphoma reveals recurrent H3K27M mutations linked to progression-free survival
title_full_unstemmed Characterization of the genomic landscape of canine diffuse large B-cell lymphoma reveals recurrent H3K27M mutations linked to progression-free survival
title_short Characterization of the genomic landscape of canine diffuse large B-cell lymphoma reveals recurrent H3K27M mutations linked to progression-free survival
title_sort characterization of the genomic landscape of canine diffuse large b cell lymphoma reveals recurrent h3k27m mutations linked to progression free survival
topic Dog
Canine
Diffuse large B-cell lymphoma
Prognosis
Genomics
Oncogenetics
url https://doi.org/10.1038/s41598-025-89245-0
work_keys_str_mv AT annadarlenevanderheiden characterizationofthegenomiclandscapeofcaninediffuselargebcelllymphomarevealsrecurrenth3k27mmutationslinkedtoprogressionfreesurvival
AT raphaelapensch characterizationofthegenomiclandscapeofcaninediffuselargebcelllymphomarevealsrecurrenth3k27mmutationslinkedtoprogressionfreesurvival
AT sophieagger characterizationofthegenomiclandscapeofcaninediffuselargebcelllymphomarevealsrecurrenth3k27mmutationslinkedtoprogressionfreesurvival
AT heatherlgardner characterizationofthegenomiclandscapeofcaninediffuselargebcelllymphomarevealsrecurrenth3k27mmutationslinkedtoprogressionfreesurvival
AT williamhendricks characterizationofthegenomiclandscapeofcaninediffuselargebcelllymphomarevealsrecurrenth3k27mmutationslinkedtoprogressionfreesurvival
AT victoriazismann characterizationofthegenomiclandscapeofcaninediffuselargebcelllymphomarevealsrecurrenth3k27mmutationslinkedtoprogressionfreesurvival
AT shukmeiwong characterizationofthegenomiclandscapeofcaninediffuselargebcelllymphomarevealsrecurrenth3k27mmutationslinkedtoprogressionfreesurvival
AT nataliabriones characterizationofthegenomiclandscapeofcaninediffuselargebcelllymphomarevealsrecurrenth3k27mmutationslinkedtoprogressionfreesurvival
AT bryceturner characterizationofthegenomiclandscapeofcaninediffuselargebcelllymphomarevealsrecurrenth3k27mmutationslinkedtoprogressionfreesurvival
AT karinforsbergnilsson characterizationofthegenomiclandscapeofcaninediffuselargebcelllymphomarevealsrecurrenth3k27mmutationslinkedtoprogressionfreesurvival
AT cheryllondon characterizationofthegenomiclandscapeofcaninediffuselargebcelllymphomarevealsrecurrenth3k27mmutationslinkedtoprogressionfreesurvival
AT kerstinlindbladtoh characterizationofthegenomiclandscapeofcaninediffuselargebcelllymphomarevealsrecurrenth3k27mmutationslinkedtoprogressionfreesurvival
AT majalouisearendt characterizationofthegenomiclandscapeofcaninediffuselargebcelllymphomarevealsrecurrenth3k27mmutationslinkedtoprogressionfreesurvival